The company that decided lab-quality diagnostics didn't actually need a lab - just a phone, a paper card, and the physics of color.
Here is a fact about diagnostic testing that the diagnostics industry would prefer you not dwell on: the expensive part is often not the chemistry. It is the reader - the boxy, calibrated, proprietary machine that looks at a test strip and turns a smudge of color into a number. Take away the reader and a lot of a diagnostic company's business model goes with it. HueDx, a small company in Philadelphia, has spent years arguing that you can, in fact, take away the reader, and that the machine you already own - your phone - can do the job if you solve one deeply unglamorous problem: lighting.
The problem is real. Ask any engineer who has tried to build a health app around a phone camera and they will tell you the same thing: the bathroom is a nightmare. Warm bulbs, cool daylight, the blue cast of a screen, a shadow from your own hand - all of it changes how a camera reads color, and color is the entire signal. HueDx's answer is a card. The HueCard is a physical test card lined with a custom color-reference border, so the phone always has a known set of colors sitting right next to the unknown one. The software normalizes against that border and reads the result the way a lab instrument would. It is a simple idea, which is usually the sign that someone worked very hard to make it look simple.
The company was, until 2023, called Group K Diagnostics. That name was a placeholder that stuck around for years, which is a common startup fate. The rebrand to HueDx did the useful thing a name should do - it described the product. Hue is the color. Dx is the diagnosis. The company reads one to produce the other.
"Quantitative diagnostics are the pathway to a healthier world."
The founder, Brianna Wronko-Stevens, did not come to this from a boardroom. She is a microfluidics researcher, and the origin story she has told repeatedly is specific in a way that invented origin stories usually are not. Working in an HIV clinic and a microfluidics lab, she watched patients fall out of the healthcare system in the gap between a visit and their results - people who needed an answer, left before it came, and did not come back. The insight was not "we should build a cool sensor." It was "the delay itself is the disease vector for losing patients."
That framing explains a lot about how HueDx is built. It is not chasing a single blockbuster FDA-cleared test. It is building the infrastructure - the tools and the cloud - that let other people develop and launch quantitative tests without owning a lab or a reader. It is, to use the well-worn phrase, a picks-and-shovels company for point-of-care diagnostics. Picks and shovels is unglamorous. It also tends to outlast the gold rush.
Wronko-Stevens founded the company around 2017 and served as its chief executive before the 2023 rebrand, after which a new CEO came aboard and she moved into the Chief Scientific Officer seat - a leadership change she framed as taking the company "to the next level." Founders handing off the CEO title to go run the science is a choice; it usually means the person knows where their edge actually is.
A paper-based colorimetric test sits in a well on the HueCard. The sample changes its color - the classic chemistry.
The phone camera captures the test alongside the card's built-in color-reference border. No dock, no dedicated reader.
Software normalizes the image against the known reference colors, cancelling out whatever lighting you happen to be in.
AI-calibrated models turn the corrected color into a quantitative result in real time and log it to the cloud.
HueDx sells to two crowds at once: the researchers and enterprise partners who need to build and validate a test, and the consumers who eventually use one. The naming is admirably literal.
The patented color-correction card. A reference border plus customizable wells for paper-based membranes - the physical thing that makes phone-camera colorimetry trustworthy.
AI-powered assay development and validation. Optimizes calibration and quantitative performance, reportedly cutting development time by up to 75%.
The platform where researchers build quantitative assays rapidly and capture real-time results data at scale.
Moves validated assays straight from development into reader-free, near-patient and direct-to-consumer use.
Consumer-facing tests - fertility/hormone and wellness - built on the same underlying color-reading platform.
An "infrastructure-free platform for modern diagnostics" - the whole lifecycle of a quantitative test without proprietary lab hardware.
The reason a platform like this is interesting - and the reason it is hard to value - is that the underlying problem is indifferent to the application. Color is everywhere in diagnostics. A test that measures a fertility hormone and a test that measures something in a farm animal or a crop are, from the camera's point of view, the same problem: read a hue, correct for light, return a number. HueDx's keyword cloud sprawls accordingly - human health, veterinary, agricultural, wellness. That breadth is either the sign of a genuine platform or a company that hasn't picked a lane. The peer-reviewed work suggests the former.
In a field where health claims outnumber citations by a wide margin, HueDx did the thing that is annoying to do and cheap to skip: it published. The HueDx color-correction system was validated in a peer-reviewed PLOS ONE paper in 2024, describing a smartphone-enabled, paper-based quantitative diagnostic assay. A citation is not a moat by itself, but in consumer health it is a rare and useful one.
"'Group K' was a placeholder. The founder wanted a name that described what the company does - use color imaging to get diagnostic results."
HueDx has raised somewhere in the range of $4M-$7M across sources and rounds, backed by a distinctly Philadelphia-and-Pennsylvania roster of investors. Then, in 2023, it did something less common for a diagnostics company: it opened the cap table to the public.
Figures are drawn from public sources (Crunchbase, PitchBook, Tracxn, company releases) and vary; treat pipeline and revenue numbers as company-reported estimates.
Rebrand from Group K Diagnostics to HueDx; new CEO steps in and founder Brianna Wronko-Stevens moves to Chief Scientific Officer.
Launches flagship HueCard / HueCloud platform and opens a Republic crowdfunding campaign.
Color-correction system validated in a peer-reviewed PLOS ONE study on smartphone-enabled quantitative diagnostics.
Founder talks and product walkthroughs are the best way to watch color turn into a number. Start with the company's own channels.